JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deguchi, Y.
Right arrow Articles by Kimura, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deguchi, Y.
Right arrow Articles by Kimura, R.

Vol. 280, Issue 2, 551-560, 1997

Quantitative Evaluation of Brain Distribution and Blood-Brain Barrier Efflux Transport of Probenecid in Rats by Microdialysis: Possible Involvement of the Monocarboxylic Acid Transport System1

Yoshiharu Deguchi, Kenji Nozawa, Shizuo Yamada, Yoshinari Yokoyama and Ryohei Kimura

Department of Biopharmacy, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

This study was performed to evaluate quantitatively the brain distribution and the efflux transport across the blood-brain barrier of probenecid, using in vivo microdialysis and in situ brain perfusion techniques. The brain interstitial fluid (ISF)-to-plasma cerebrospinal fluid (CSF)-to-plasma and brain tissue-to-plasma unbound concentration ratios of probenecid at steady state were less than unity, which suggests restricted distribution in the brain. An uphill concentration gradient from ISF to plasma and a downhill concentration gradient from CSF to ISF were observed. Kinetic analysis revealed that the efflux clearance from brain ISF to plasma (0.0373 ml/min/g brain) was significantly greater than the influx clearance from plasma to brain (0.00733 ml/min/g brain). The ratio of the ISF concentration (Cisf) to the plasma unbound concentration (Cp,f) of probenecid was increased 2- to 3-fold by salicylate (3.7 mM) and benzoate (3.6 mM), which are accepted as substrates of the monocarboxylic acid transport system, compared with the same ratio for the control. In addition, the ratio Cisf/Cp,f was increased by treatment with N-ethylmaleimide, a sulfhydryl-modifying agent, whereas p-aminohippuric acid and choline did not produce increasing effects on Cisf/Cp,f. These data suggest that the restricted distribution of probenecid in the brain may be ascribed to efficient efflux from the brain ISF, which may be regulated by the monocarboxylic acid transport system at a relatively high ISF concentration.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
I. Bhattacharya and K. M. K. Boje
GHB ({gamma}-Hydroxybutyrate) Carrier-Mediated Transport across the Blood-Brain Barrier
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 92 - 98.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
R. Yan and E. M. Taylor
Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
Drug Metab. Dispos., May 1, 2002; 30(5): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, Y. Shima, K. Naruhashi, S. Koizumi, and A. Tsuji
Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 146 - 152.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Kitazawa, T. Terasaki, H. Suzuki, A. Kakee, and Y. Sugiyama
Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides
J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 890 - 895.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.